Microbot Medical (MBOT) Gross Margin (2010 - 2026)

Microbot Medical (MBOT) reported Gross Margin of 1.9% for Q1 2026, down 94.59% quarter-over-quarter from 35.23% in Q1 2017.

Microbot Medical (MBOT) Gross Margin (2010 - 2026) Analysis & Trends

Microbot Medical has reported Gross Margin for 7 years, with the latest figure at 1.9% in Q1 2026.

For the quarter ending Q1 2026, Gross Margin changed N/A year-over-year to 1.9%; the trailing twelve-month figure through Mar 2026 stood at 115.58% (changed N/A YoY), and the FY2017 full-year result was 85.47%, up 5824.0% from the prior year.
Gross Margin for Q1 2026 stood at 1.9%, down from 35.23% in the prior quarter.
The five-year high for Gross Margin was 1.9% in Q1 2026, with the low at 1.9% in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	66.06%
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	45.69%
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	25.04%
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	62.25%
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	35.08%
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	54.66%
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	68.00%
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	70.82%
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	32.99%
10	Microbot Medical	122.56 Mn	52.91 Mn	2,000.00	1.90%

Historic Data

Download Data

Date	Value
Mar 31, 2026	1.90%
Mar 31, 2017	35.23%
Sep 30, 2014	257.93%
Jun 30, 2014	713.51%
Mar 31, 2014	1,050.85%
Dec 31, 2013	502.47%
Sep 30, 2013	629.08%
Jun 30, 2013	618.56%
Mar 31, 2013	388.14%
Dec 31, 2012	73.95%
Sep 30, 2012	72.77%
Jun 30, 2012	74.12%
Mar 31, 2012	88.83%
Dec 31, 2011	337.84%
Sep 30, 2011	89.45%
Jun 30, 2011	77.63%
Mar 31, 2011	111.76%
Dec 31, 2010	352.15%
Sep 30, 2010	167.61%
Jun 30, 2010	89.82%